Article in the Journal Science on Cardiac Drug Inactivation by Gut Bacteria

July 19, 2013

Congratulations to Henry Haiser, Peter Turnbaugh and our own Kelly Chatman for their manuscript in the journal Science entitled "Predicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lenta".  Kelly's project with Henry involved the targeted quantification of the cardiac drug digoxin, and its metabolites to discover how differences in gut microbiome can affect drug metabolism (Science, July 19th 2013, Vol. 341, 6143, pp. 295-298).